P5272Concomitant heart failure (HF) and type 2 diabetes (T2D) - a deadly duo
نویسندگان
چکیده
منابع مشابه
Deadly duo
An astonishing one-third of the world’s population is infected with the bacterium that causes tuberculosis (TB), Mycobacterium tuberculosis. In most people it remains inactive or latent but in about 10% of people an active case of TB disease will develop within their lifetime. Simple antibiotics can prevent and treat most of these cases, yet 8-10 million people develop an active TB infection an...
متن کاملHIV & TB “ The Deadly Duo ”
WHO estimates that more than 7 million people, 98% of whom are in the developing world are co-infected with HIV and TB. The situation is explosive, leading to unprecedented public health crises. Both diseases are devastating but the devastation of the TB /HIV co-epidemic surpasses the devastation of either disease on its own. An estimated 1.4 million new cases of HIV-TB occurred in 2008, repres...
متن کاملType 2 diabetes mellitus and thyroid dysfunction: an intertwined duo
Introduction Diabetes and thyroid diseases are two common endocrinopathies seen in the general population. Diabetes is a group of aetiologically different metabolic defects characterised by hyperglycaemia resulting from defects in insulin secretion, insulin action, or both. The World Health Organization (WHO) has projected that the global prevalence of diabetes will rise to 300 million (7.8%) b...
متن کاملType 2 Diabetes and Heart Failure: Challenges and Solutions
Increasing numbers of older patients with type 2 diabetes, and their improved survival from cardiovascular events is seeing a massive increase in patients with both diabetes and heart failure. Already, at least a third of all patients with heart failure have diabetes. This close association is partly because all the major risk factors for heart failure also cluster in patients with type 2 diabe...
متن کاملHeart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes.
Prevalent and incident heart failure (HF) is increased in people with type 2 diabetes mellitus, with risk directly associated with the severity of hyperglycemia. Furthermore, in patients with type 2 diabetes mellitus, mortality is increased ≈10-fold in patients with versus without HF. Reducing HF with antihyperglycemic therapies, however, has been unsuccessful until recently. In fact, HF as an ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: European Heart Journal
سال: 2017
ISSN: 0195-668X,1522-9645
DOI: 10.1093/eurheartj/ehx493.p5272